NexImmune Inc (NEXI)
3.60
+0.14
(+4.05%)
USD |
NASDAQ |
May 10, 16:00
3.49
-0.11
(-3.06%)
After-Hours: 20:00
NexImmune Price to Book Value: 1.406 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 1.406 |
| May 09, 2024 | 1.352 |
| May 08, 2024 | 1.320 |
| May 07, 2024 | 1.402 |
| May 06, 2024 | 1.375 |
| May 03, 2024 | 1.297 |
| May 02, 2024 | 1.219 |
| May 01, 2024 | 1.242 |
| April 30, 2024 | 1.313 |
| April 29, 2024 | 1.281 |
| April 26, 2024 | 1.316 |
| April 25, 2024 | 1.332 |
| April 24, 2024 | 1.274 |
| April 23, 2024 | 1.34 |
| April 22, 2024 | 1.424 |
| April 19, 2024 | 1.363 |
| April 18, 2024 | 1.289 |
| April 17, 2024 | 1.231 |
| April 16, 2024 | 1.356 |
| April 15, 2024 | 1.387 |
| April 12, 2024 | 1.410 |
| April 11, 2024 | 1.539 |
| April 10, 2024 | 1.545 |
| April 09, 2024 | 1.414 |
| April 08, 2024 | 1.680 |
| Date | Value |
|---|---|
| April 05, 2024 | 1.449 |
| April 04, 2024 | 1.789 |
| April 03, 2024 | 1.973 |
| April 02, 2024 | 2.094 |
| April 01, 2024 | 2.180 |
| March 28, 2024 | 2.192 |
| March 27, 2024 | 2.152 |
| March 26, 2024 | 2.223 |
| March 25, 2024 | 2.246 |
| March 22, 2024 | 2.203 |
| March 21, 2024 | 2.293 |
| March 20, 2024 | 2.235 |
| March 19, 2024 | 2.250 |
| March 18, 2024 | 2.188 |
| March 15, 2024 | 2.262 |
| March 14, 2024 | 2.364 |
| March 13, 2024 | 2.379 |
| March 12, 2024 | 2.297 |
| March 11, 2024 | 2.328 |
| March 08, 2024 | 2.344 |
| March 07, 2024 | 2.461 |
| March 06, 2024 | 2.551 |
| March 05, 2024 | 2.539 |
| March 04, 2024 | 2.332 |
| March 01, 2024 | 2.418 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1128
Minimum
Dec 28 2022
4.615
Maximum
Feb 01 2024
1.268
Average
0.6496
Median
Price to Book Value Benchmarks
| Mind Medicine Inc | 3.395 |
| Candel Therapeutics Inc | 21.46 |
| Ventyx Biosciences Inc | 0.9933 |
| NKGen Biotech Inc | -- |
| CERo Therapeutics Holdings Inc | -- |
Price to Book Value Related Metrics
| Price | 3.60 |
| Earnings Yield | -858.1% |
| Market Cap | 4.936M |